Clinical Pharmacology Study for Noodle Containing Calcium Alginate-Additional study B
Not Applicable
Completed
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000032976
- Lead Sponsor
- Fukushima Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Those who have allergic symptoms to alcohol. 2)Those who are suspected not to have intact gut absorption. 3)Those whose HbA1c(NGSP) is higher than 6.5%. 4)those who are considered as inappropriate for this study by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose of profile after meal
- Secondary Outcome Measures
Name Time Method Blood IRI,Total-cholesterol,HDL-cholesterol,LDL-cholesterol,UA,BUN and Ca level
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the mechanism of action of calcium alginate in modulating intestinal absorption of minerals in healthy adults?
How does calcium alginate compare to other dietary fiber supplements in enhancing gut barrier function and mineral bioavailability?
Are there specific biomarkers that correlate with improved mineral retention following calcium alginate consumption in clinical studies?
What are the potential adverse effects of long-term calcium alginate ingestion and how are they managed in clinical practice?
What is the therapeutic potential of calcium alginate-based foods in managing mineral imbalances in gastrointestinal disorders compared to conventional supplements?